A synthetic melanocortin receptor agonist. Research applications include investigation of MC1R and MC4R signalling pathways and cAMP modulation in cellular receptor binding assays.
Add sterile bacteriostatic water to the vial to achieve your target working concentration.
Storage conditions: -20°C, dry
Form: Lyophilised
Solubility: Water, BAC water
Current batch: BSR-PEP-010-2601
HPLC purity: 98.50%
MS verified: Yes
Expiry: Jun 2027
COA upload in progress.
C₅₀H₆₈N₁₄O₁₀ · 1,025.2 Da
PT-141 Bremelanotide (PT-141)
out of stock
Free shipping on orders over £75
Working out volumes? Peptide calculator · Reconstitution guide
BSR-PEP-010-2601 · HPLC 98.50%
The batch code matches the vial you will receive. Full analysis — purity, mass spectrometry, residual solvents and microbial limits — is issued with your order.
| Content | 10mg |
| Purity | 98.50% HPLC |
| Form | Lyophilised |
| Storage | -20°C, dry |
| Solubility | Water, BAC water |
Same-day dispatch — order within
Same-day dispatch before 3pm, Mon–Fri. Next dispatch .
via Royal Mail Tracked 24
PT-141
10mg · £29.99
PT-141 is bremelanotide, a melanocortin receptor agonist derived from the alpha-MSH family. Unlike most compounds in this catalogue it has been through full regulatory approval elsewhere: Dhillon and Keam documented its first approval in Drugs in 2019.
That approval is for a licensed medicine in another jurisdiction. Material supplied by BSR is research material, not that product, and is not authorised for use in people.
Mechanism in the literature
Bremelanotide is a parenterally administered melanocortin receptor agonist. The melanocortin system is distinct from the incretin and growth hormone pathways covered elsewhere in this catalogue.
The clinical literature concerns an approved medicine used under prescription. It is not guidance for research material, and nothing here should be read as suggesting use in people.
Handling and reconstitution
Supplied lyophilised at 10mg and 20mg. Room temperature before reconstitution, diluent down the vial wall, gentle swirling.
Storage and stability
Lyophilised at -20°C, protected from light. Reconstituted solution refrigerated and used within a short window.
Common questions
Is a certificate of analysis available for PT-141?
Not for the current batch. Certificates are issued with orders for the compounds where we hold one, and PT-141 is awaiting analysis — which is why no purity figure appears on this page.
What is the difference between PT-141 and bremelanotide?
They are the same compound. PT-141 is the development code and bremelanotide the approved name.
Cited as research context. BSR has no involvement in these studies and they do not constitute claims about this product.
No reviews of this compound yet. Reviews come only from customers who have bought it.
Sign in to review a compound you have bought.